Clinical Cancer Research Landon Prizes for Basic and Translational Cancer Research Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krassenstein, R.
Right arrow Articles by Cairns, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krassenstein, R.
Right arrow Articles by Cairns, P.
Clinical Cancer Research Vol. 10, 28-32, January 2004
© 2004 American Association for Cancer Research


Clinical Trials

Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation

Rachel Krassenstein1, Edward Sauter3, Essel Dulaimi1, Cristina Battagli1, Hormoz Ehya2, Andres Klein-Szanto2 and Paul Cairns12

1Departments of Surgical Oncology and2 Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, and3 Department of Surgery, Ellis Fischel Cancer Center/University of Missouri, Columbia, Missouri

ABSTRACT

Purpose: New approaches to the early detection of breast cancer are urgently needed as there is more benefit to be realized from screening. Nipple aspiration is a noninvasive technique that yields fluid known to contain breast epithelial cells. Silencing of tumor suppressor genes such as p16INk4a, BRCA1, and hMLH1 have established hypermethylation as a common mechanism for tumor suppressor inactivation in human cancer and as a promising target for molecular detection.

Experimental Design: Using sensitive methylation-specific PCR, we searched for aberrant promoter hypermethylation in a panel of six normally unmethylated genes: glutathione S-transferase {pi} 1 (GSTP1); retinoic acid receptor-ß2 (RARß2); p16INk4a; p14ARF; RAS association domain family protein 1A (RASSF1A); and death-associated protein kinase (DAP-kinase) in 22 matched specimens of tumor, normal tissue, and nipple aspirate fluid collected from breast cancer patients.

Results: Hypermethylation of one or more genes was found in all 22 tumor DNAs (100% diagnostic coverage) and identical gene hypermethylation detected in 18 of 22 (82%) matched aspirate fluid DNAs. In contrast, hypermethylation was absent in benign and normal breast tissue and nipple aspirate DNA from healthy women.

Conclusions: Promoter hypermethylation of important cancer genes is common in breast cancer and could be detected in matched aspirate DNAs from patients with ductal carcinoma in situ or stage I cancer. Promoter hypermethylation represents a promising marker, and larger studies may lead to its useful application in breast cancer diagnosis and management.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
D. E. Freedberg, S. H. Rigas, J. Russak, W. Gai, M. Kaplow, I. Osman, F. Turner, J. A. Randerson-Moor, A. Houghton, K. Busam, et al.
Frequent p16-Independent Inactivation of p14ARF in Human Melanoma
J Natl Cancer Inst, June 4, 2008; 100(11): 784 - 795.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Luxen, S. A. Belinsky, and U. G. Knaus
Silencing of DUOX NADPH Oxidases by Promoter Hypermethylation in Lung Cancer
Cancer Res., February 15, 2008; 68(4): 1037 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-J. Zhang, H.-C. Wu, J. Shen, H. Ahsan, W. Y. Tsai, H.-I Yang, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella
Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA
Clin. Cancer Res., April 15, 2007; 13(8): 2378 - 2384.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Visvanathan, S. Sukumar, and N. E. Davidson
Epigenetic Biomarkers and Breast Cancer: Cause for Optimism.
Clin. Cancer Res., November 15, 2006; 12(22): 6591 - 6593.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
B. TABACK, A. E GIULIANO, R. LAI, N. HANSEN, F. R SINGER, K. PANTEL, and D. S.B HOON
Epigenetic Analysis of Body Fluids and Tumor Tissues: Application of a Comprehensive Molecular Assessment for Early-Stage Breast Cancer Patients.
Ann. N.Y. Acad. Sci., September 1, 2006; 1075: 211 - 221.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. C. Antill, G. Mitchell, S. A. Johnson, L. Devereux, A. Milner, K.-A. Phillips, and I. G. Campbell
Loss of Heterozygosity Analysis in Ductal Lavage Samples from BRCA1 and BRCA2 Carriers: A Cautionary Tale.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1396 - 1398.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
P. Cairns
Serum-Based Detection of Gene Hypermethylation in Cancers of the Breast and Ovary
Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 202 - 204.
[Full Text] [PDF]


Home page
JCOHome page
R. S. Dua, C. M. Isacke, and G. P.H. Gui
The Intraductal Approach to Breast Cancer Biomarker Discovery
J. Clin. Oncol., March 1, 2006; 24(7): 1209 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Sartippour, L. Zhang, M. Lu, H.-J. Wang, and M. N. Brooks
Nipple Fluid Basic Fibroblast Growth Factor in Patients with Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2995 - 2998.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Liu, L.-E Wang, L. Wang, K. H. Lu, G. B. Mills, M. L. Bondy, and Q. Wei
Methylation and Messenger RNA Expression of p15INK4b but Not p16INK4a Are Independent Risk Factors for Ovarian Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4968 - 4976.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C J Fabian, B F Kimler, M S Mayo, and S A Khan
Breast-tissue sampling for risk assessment and prevention
Endocr. Relat. Cancer, June 1, 2005; 12(2): 185 - 213.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
K. Miyamoto and T. Ushijima
Diagnostic and Therapeutic Applications of Epigenetics
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Agathanggelou, W. N. Cooper, and F. Latif
Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Cancer Res., May 1, 2005; 65(9): 3497 - 3508.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. W. Laird
Cancer epigenetics
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R65 - R76.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Zhu, W. Qin, P. Bradley, A. Wessel, C. L. Puckett, and E. R. Sauter
Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid
Carcinogenesis, January 1, 2005; 26(1): 145 - 152.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Dulaimi, J. Hillinck, I. I. de Caceres, T. Al-Saleem, and P. Cairns
Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients
Clin. Cancer Res., September 15, 2004; 10(18): 6189 - 6193.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.